FDA Panel Reconsiders Avandia Restrictions

Two-Day Advisory Panel for the FDA Considers Lifting Restrictions on Avandia Sales in the US In 2010, serious health concerns related to the use of Avandia forced the FDA to put strong warning labels on the drug. European pharmacies pulled the drug from shelves, and only about 3,000 people in the US currently take Avandia, despite concerns about … [Read more...]

FDA Lifts Avandia Restriction

FDA Lifts Some Restrictions on Prescribing Avandia to Reflect New Cardiovascular Research Results from a new study have led the Food and Drug Administration to lift restrictions for doctors on prescribing the controversial drug Avandia. The clinical trial, Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycemia in Diabetes … [Read more...]

BestLawyers.comAVBetter Business Bureau